SEARCH

SEARCH BY CITATION

References

  • Banerjee I, Ramani S, Primrose B et al. (2006) Comparative study of the epidemiology of rotavirus in children from a community-based cohort and a hospital in South India. Journal of Clinical Microbiology 44, 24682474.
  • Banerjee I, Gladstone BP, LeFevre AM et al. (2007) Neonatal infection with G10P[11] rotavirus does not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. Journal of Infectious Diseases 195, 625632.
  • Bresee JS, Glass RI, Ivanoff B & Gentsch J (1999) Current status and future priorities for rotavirus vaccine development, evaluation, and implementation in developing countries. Vaccine 17, 22072222.
  • Fischer TK, Anh DD, Antil L et al. (2005) Health care costs of diarrhoeal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. Journal of Infectious Diseases 192, 17201726.
  • Giaquinto C, Van Damme P, Huet F, Gothefors L & Van der Wielen M (2007) Cost of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the reveal study. Journal of Infectious Diseases 195, S36S44.
  • Isakbaeva ET, Musabaev E, Antil L et al. (2007) Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 25, 373380.
  • Jain V, Parashar UD, Glass RI & Bhan MK (2000) Epidemiology of rotavirus in India. Indian Journal of Pediatrics 68, 855862.
  • Lu CY, Lauderdale TL, Fang YH et al. (2006) Disease burden and related medical costs of rotavirus infections in Taiwan. BMC Infectious Diseases 6, 176184.
  • Nelson EA, Tam JS, Yu LM et al. (2005) Hospital-based study of the economic burden associated with rotavirus diarrhoea in Hong Kong. Journal of Infectious Diseases 192, S64S70.
  • Parashar UD, Hummelman EJ, Bresee JS, Miller MA & Glass RI (2003) The global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases 9, 565572.
  • Parashar UD, Gibson CJ, Bresee JS & Glass RI (2006) Rotavirus and severe childhood diarrhea. Emerging Infectious Diseases 12, 304306.
  • Podewils LJ, Antil L, Hummelman E et al. (2005) Projected cost-effectiveness of rotavirus vaccination for children in Asia. Journal of Infectious Diseases 192, S133S145.
  • Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al. (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 354, 1122.
  • Vesikari T, Matson DO, Dennehy P et al. (2006) Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 354, 2333.
  • WHO (2005) Guidelines for Estimating the Economic Burden of Diarrhoeal Disease with Focus on Assessing the Costs of Rotavirus Diarrhoea. (WHO/IVB/05.10) WHO, Geneva.
  • WHO (2007) World Health Statistics 2007. Health financing. http://www.who.int/whosis/database/core/core_select_process.cfm?countries=all&indicators=nha. Accessed: 25 June 2007.
  • Zimmerman CM, Bresee JS, Parashar UD, Riggs TL, Holman RC & Glass RI (2001) Cost of diarrhoea-associated hospitalisations and outpatient visits in an insured population of young children in the United States. Pediatric Infectious Diseases Journal 20, 1419.